Female patients with baseline CD4+ T-cell count >500 cells/μL, those with FPG >6.2 mmol/L, and patients with Hb ≤110 g/L had 0.72 times, 2.49 times, 2.08 times, and 0.59 times higher risk of developing hyperlipidemia, respectively. Here, GSTM1 is linked to hyperlipidemia.